A Trial of Atorvastatin as an Anti-Inflammatory Agent in Non-Cystic Fibrosis Bronchiectasis

NCT01299181 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Bronchiectasis

Interventions

DRUG: Atorvastatin

Sponsor

University of Edinburgh

Collaborators

[object Object]